Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells

Archives of Virology

Volumn 153, Issue 3, 2008, Pages 561-565

  Riva, D A ^a   Fernandez Larrosa P N ^a   Dolcini, G L ^a   Martinez Peralta L A ^a   Coulombie F C ^a   Mersich, S E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CURCUMIN; ENZYME INHIBITOR; GAG PROTEIN; INDINAVIR; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; PROTEINASE INHIBITOR; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL LINE; CELL SURVIVAL; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SURVIVAL; CURCUMIN; DRUG SYNERGISM; ENZYME INHIBITORS; HIV CORE PROTEIN P24; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; PROTEIN-SERINE-THREONINE KINASES; SULFASALAZINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 39749151689     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-007-0023-4     Document Type: Article

References (26)